Expression of ALDH1A1 and CD44 in primary head and neck squamous cell carcinoma and their value for carcinogenesis, tumor progression and cancer stem cell identification

Oncology Letters

Volumn 10, Issue 4, 2015, Pages 2289-2294

  Leinung, Martin ^a   Ernst, Benjamin ^a   Döring, Constanze ^a   Wagenblast, Jens ^a   Tahtali, Aykut ^a   Diensthuber, Marc ^a   Stöver, Timo ^a   Geissler, Christin ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

ALDH1A1; Cancer stem cells; CD44; Head and neck squamous cell carcinoma

Indexed keywords

ALDEHYDE DEHYDROGENASE; EPIDERMAL GROWTH FACTOR RECEPTOR; HERMES ANTIGEN; PROTEIN ALDH1A1; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN RETRIEVAL; ARTICLE; CANCER STEM CELL; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 84940039135     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.3542     Document Type: Article

References (34)

1. Leemans CR, Braakhuis BJ and Brakenhoff RH: The molecular biology of head and neck cancer. Nat Rev Cancer 11: 9-22, 2011.
2. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: GLOBOCAN 2012, cancer incidence and mortality worldwide: IARC cancerbase No. 11 [Internet]. Lyon, France, IARC v1.0, 2013.
3. Wu MJ, Jan CI, Tsay YG, Yu YH, Huang CY, Lin SC, Liu CJ, Chen YS, Lo JF and Yu CC: Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling. Mol Cancer 9: 283, 2010.
4. Chen YC, Chen YW, Hsu HS, Tseng LM, Huang PI, Lu KH, Chen DT, Tai LK, Yung MC, Chang SC, et al: Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun 385: 307-313, 2009.
5. Clay MR, Tabor M, Owen JH, Carey TE, Bradford CR, Wolf GT, Wicha MS and Prince ME: Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck 32: 1195-1201, 2010.
6. Visus C, Ito D, Amoscato A, Maciejewska-Franczak M, Abdelsalem A, Dhir R, Shin DM, Donnenberg VS, Whiteside TL and DeLeo AB: Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck. Cancer Res 67: 10538-10545, 2007.
7. Ma I and Allan AL: The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev 7: 292-306, 2011.
8. Singh S, Brocker C, Koppaka V, Chen Y, Jackson BC, Matsumoto A, Thompson DC and Vasiliou V: Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress. Free Radic Biol Med 56: 89-101, 2013.
9. Turley EA, Noble PW and Bourguignon LY: Signaling properties of hyaluronan receptors. J Biol Chem 277: 4589-4592, 2002.
10. Wang SJ and Bourguignon LY: Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance. Am J Pathol 178: 956-963, 2011.
11. Kokko LL, Hurme S, Maula SM, Alanen K, Grénman R, Kinnunen I and Ventelä S: Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma. Oral Oncol 47: 510-516, 2011.
12. Edge SB and Compton CC: The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17: 1471-1474, 2010.
13. Gillespie MB, Rubinchik S, Hoel B and Sutkowski N: Human papillomavirus and oropharyngeal cancer: What you need to know in 2009. Curr Treat Options Oncol 10: 296-307, 2009.
14. Hedberg JJ, Grafström RC, Vondracek M, Sarang Z, Wärngård L and Höög JO: Micro-array chip analysis of carbonyl-metabolising enzymes in normal, immortalised and malignant human oral keratinocytes. Cell Mol Life Sci 58: 1719-1726, 2001.
15. Kato H, Izumi K, Saito T, Ohnuki H, Terada M, Kawano Y, Nozawa-Inoue K, Saito C and Maeda T: Distinct expression patterns and roles of aldehyde dehydrogenases in normal oral mucosa keratinocytes: Differential inhibitory effects of a pharmacological inhibitor and RNAi-mediated knockdown on cellular phenotype and epithelial morphology. Histochem Cell Biol 139: 847-862, 2013.
16. Sherman JA and Partridge M: Expression of retinoic acid receptors in normal, dysplastic and malignant oral epithelia. Br J Oral Maxillofac Surg 35: 260-266, 1997.
17. Makia NL, Amunom I, Falkner KC, Conklin DJ, Surapureddi S, Goldstein JA and Prough RA: Activator protein-1 regulation of murine aldehyde dehydrogenase 1a1. Mol Pharmacol 82: 601-613, 2012.
18. Maddox J, Shakya A, South S, Shelton D, Andersen JN, Chidester S, Kang J, Gligorich KM, Jones DA, Spangrude GJ, et al: Transcription factor Oct1 is a somatic and cancer stem cell determinant. PLoS Genet 8: e1003048, 2012.
19. Wang P and Jin T: Oct-1 functions as a sensor for metabolic and stress signals. Islets 2: 46-48, 2010.
20. Wong HK and Ziff EB: The human papillomavirus type 16 E7 protein complements adenovirus type 5 E1A amino-terminus-dependent transactivation of adenovirus type 5 early genes and increases ATF and Oct-1 DNA binding activity. J Virol 70: 332-340, 1996.
21. Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, Zwahlen M, Kampf C, Wester K, Hober S, et al: Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 28: 1248-1250, 2010. Available from: http://www.proteinatlas.org
22. Qian X, Wagner S, Ma C, Coordes A, Gekeler J, Klussmann JP, Hummel M, Kaufmann AM and Albers AE: Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma. J Cancer Res Clin Oncol 140: 1151-1158, 2014.
23. Mack B and Gires O: CD44 s and CD44v6 expression in head and neck epithelia. PLoS One 3: e3360, 2008.
24. Sterz CM, Kulle C, Dakic B, Makarova G, Böttcher MC, Bette M, Werner JA and Mandic R: A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9. Oral Oncol 46: 116-122, 2010.
25. Richard V and Pillai MR: The stem cell code in oral epithelial tumorigenesis: 'the cancer stem cell shift hypothesis'. Biochim Biophys Acta 1806: 146-162, 2010.
26. Williams K, Motiani K, Giridhar PV and Kasper S: CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches. Exp Biol Med 238: 324-338, 2013.
27. Wang SJ and Bourguignon LY: Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer. Arch Otolaryngol Head Neck Surg 132: 771-778, 2006.
28. Bourguignon LY, Gilad E, Brightman A, Diedrich F and Singleton P: Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling and cytoskeleton modification in head and neck squamous cell carcinoma cells. J Biol Chem 281: 14026-14040, 2006.
29. Abhold EL, Kiang A, Rahimy E, Kuo SZ, Wang-Rodriguez J, Lopez JP, Blair KJ, Yu MA, Haas M, Brumund KT, et al: EGFR kinase promotes acquisition of stem cell-like properties: a potential therapeutic target in head and neck squamous cell carcinoma stem cells. PLoS One 7: e32459, 2012.
30. Brabletz T, Jung A, Spaderna S, Hlubek F and Kirchner T: Opinion: Migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat Rev Cancer 5: 744-749, 2005.
31. Brabletz T: EMT and MET in metastasis: Where are the cancer stem cells? Cancer Cell 22: 699-701, 2012.
32. Biddle A, Liang X, Gammon L, Fazil B, Harper LJ, Emich H, Costea DE and Mackenzie IC: Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative. Cancer Res 71: 5317-5326, 2011.
33. Liu S, Clouthier SG and Wicha MS: Role of microRNAs in the regulation of breast cancer stem cells. J Mammary Gland Biol Neoplasia 17: 15-21, 2012.
34. French R and Clarkson R: The complex nature of breast cancer stem-like cells: Heterogeneity and plasticity. J Stem Cell Res Ther S7: 009, 2012.